Simpson Thacher & Bartlett LLP has advised OceanFirst Financial Corp. on its merger with Flushing Financial Corp. and the concurrent investment by Warburg Pincus. Hughes Hubbard...
OceanFirst Financial to Merge with Flushing Financial and Announce $225 Million Investment from Warburg Pincus
Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy
Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal. Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used...
Brook + Whittle’s Acquisition of Cenveo Custom Labels Group
Hughes Hubbard & Reed represented Cenveo in the transaction while O’Melveny represented Brook + Whittle. Brook + Whittle, a leading provider of pressure sensitive and shrink...
Tao Group Hospitality’s Combination With Hakkasan Group
Hughes Hubbard advised Tao Group Hospitality on the deal. Tao Group Hospitality entered into an agreement to acquire majority control of Hakkasan Group, creating a premium...
Wabtec’s $400 Million Acquisition of Nordco
Hughes Hubbard & Reed LLP represented Greenbriar Equity Group and Nordco in the transaction. Wabtec signed an agreement to purchase Nordco for $400 million in cash, financed...
Spireon’s Acquisition of CalAmp’s LoJack U.S. Stolen Vehicle Recovery Business
Hughes Hubbard & Reed LLP represented Spireon in the transaction. CalAmp (Nasdaq: CAMP) and Spireon executed the acquisition of the LoJack® U.S. Stolen Vehicle Recovery (SVR) business from CalAmp. The integration...
ANI Pharmaceuticals’ Acquisiiton of Novitium Pharma
Hughes Hubbard & Reed LLP represented ANI Pharmaceuticals in the transaction. ANI Pharmaceuticals signed an agreement to acquire Novitium Pharma for $89.5 million in cash and $74 million...
CF Finance Acquisition Corp. III’s Merger With AEye
DLA Piper LLP (US) served AEye, while Hughes Hubbard & Reed LLP and Ellenoff Grossman & Schole LLP are serving as legal advisors to CF III...